Reduced membrane attack complex formation in umbilical cord blood during Eculizumab treatment of the mother: a case report

[1]  J. Wetzels,et al.  Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  J. Wetzels,et al.  Eculizumab Dosing Regimen in Atypical HUS: Possibilities for Individualized Treatment , 2017, Clinical pharmacology and therapeutics.

[3]  G. Remuzzi,et al.  Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis , 2017, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  J. Nezu,et al.  Long lasting neutralization of C5 by SKY59, a novel recycling antibody, is a potential therapy for complement-mediated diseases , 2017, Scientific Reports.

[5]  L. Salomon,et al.  Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  J. Arredondo,et al.  Blood SC5b-9 complement levels increase at parturition during term and preterm labor. , 2015, Journal of reproductive immunology.

[7]  J. Andersen,et al.  Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn. , 2015, Immunobiology.

[8]  G. Remuzzi,et al.  Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies , 2015, Kidney international.

[9]  D. Kavanagh,et al.  Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. , 2015, Translational research : the journal of laboratory and clinical medicine.

[10]  D. Kavanagh,et al.  Atypical Hemolytic Uremic Syndrome , 2013, Seminars in nephrology.

[11]  A. Malek.  Role of IgG antibodies in association with placental function and immunologic diseases in human pregnancy , 2013, Expert review of clinical immunology.

[12]  K. Skjødt,et al.  Novel assays to assess the functional capacity of the classical, the alternative and the lectin pathways of the complement system , 2011, Clinical and experimental immunology.

[13]  K. Skjødt,et al.  Generation of a C3c specific monoclonal antibody and assessment of C3c as a putative inflammatory marker derived from complement factor C3. , 2010, Journal of immunological methods.

[14]  J. Goodship,et al.  Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome , 2007, PLoS genetics.

[15]  Econor,et al.  ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS , 2002 .